Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.
- befree-2016 importedOn "2016-02-19" NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.
- NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_assertion wasGeneratedBy ECO_0000203 NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.
- NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_assertion wasDerivedFrom befree-2016 NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.
- NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_assertion SIO_000772 16912221 NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.
- NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_assertion evidence source_evidence_literature NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.
- NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_assertion description "[Finally, Syk inhibition by piceatannol or by siRNA plasmids resulted in a potent inhibition of mTOR activity in FL cells, as well as in mantle cell lymphoma, Burkitt lymphoma, and diffuse large B-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564519.RAaK-KgBJvZECQe92Sbep0O-QMSxjYl3MLbEKyOr8iE-U130_provenance.